Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could a gentle zap to the neck ease restless legs in dialysis patients?

NCT ID NCT07657013

Symptom relief Sponsor: Cairo University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a non-invasive device that sends mild electrical pulses to nerves in the neck can reduce restless legs syndrome in people undergoing dialysis. Thirty-six adults aged 40-50 will receive either real or sham stimulation three times a week for four weeks. Researchers will measure changes in symptom severity, sleep quality, pain, blood pressure, and mood.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
transcutaneous electrical nerve stimulation (TENS) device
What this could lead to
If it works, this could offer a safe, non-drug option to relieve restless legs and improve sleep and well-being for people on dialysis.
What could go wrong
This is a small, early-stage trial with only 36 participants, so results may not apply to everyone. The effect may be modest or not last long-term.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

36 people

The number who actually took part.

Started

Oct 2025

Finished

May 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

40 to 50 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * 36 patients will be involved in this study according to the following criteria * Patient undergoes four main clinical criteria for the diagnosis of RLS according to the international restless leg syndrome study group (IRLSSG) including 1. an urge to move legs that is usually associated with paresthesia. 2. alleviation of the symptoms by moving the legs. 3. aggravation or exacerbation of the symptoms particularly at rest or during sitting or lying down in the bed. 4. worsening of the signs at night. * Male and Female patients. * The age will range from 40-50 years old. * BMI (Body Mass Index 25-34.9 kg/m2 * Patients with grade 2 Hypertension (160-179/100-109 mmHg) * Hemodialysis patients for at least 1year and have restless leg syndrome (RLS). Exclusion Criteria: * History of Deep venous thrombosis * History of Bleeding disorders * Have an implantable device like a pacemaker * Recent Infected wound * History of allergic response to the electrodes, gel or tape * patients who participating in any other exercise program * Loss of sensation or numbness

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for End-stage renal disease on hemodialysis are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

end stage renal failure restless legs syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Hemodialysis Restless leg syndrome (RLS)

Contacts and locations

Locations

  • Faculty of Physical Therapy, Cairo University

    Cairo, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.